CN1313342A - Human testis lactate dehydrogenase A gene coded protein - Google Patents
Human testis lactate dehydrogenase A gene coded protein Download PDFInfo
- Publication number
- CN1313342A CN1313342A CN 01108262 CN01108262A CN1313342A CN 1313342 A CN1313342 A CN 1313342A CN 01108262 CN01108262 CN 01108262 CN 01108262 A CN01108262 A CN 01108262A CN 1313342 A CN1313342 A CN 1313342A
- Authority
- CN
- China
- Prior art keywords
- gene
- lactate dehydrogenase
- human testis
- testis
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000001550 testis Anatomy 0.000 title claims abstract description 34
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 30
- 108010088350 Lactate Dehydrogenase 5 Proteins 0.000 title claims abstract description 26
- 102000004169 proteins and genes Human genes 0.000 title abstract description 7
- 230000014509 gene expression Effects 0.000 claims abstract description 10
- 108700026244 Open Reading Frames Proteins 0.000 claims abstract description 7
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- 150000001413 amino acids Chemical class 0.000 claims abstract description 3
- 239000002299 complementary DNA Substances 0.000 claims abstract 2
- 238000002965 ELISA Methods 0.000 claims description 4
- 230000004927 fusion Effects 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 210000004027 cell Anatomy 0.000 claims description 3
- 210000004408 hybridoma Anatomy 0.000 claims description 3
- 241000283977 Oryctolagus Species 0.000 claims description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 claims description 2
- 201000000050 myeloid neoplasm Diseases 0.000 claims description 2
- 210000000952 spleen Anatomy 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 3
- 238000012408 PCR amplification Methods 0.000 claims 1
- 235000001014 amino acid Nutrition 0.000 claims 1
- 210000001185 bone marrow Anatomy 0.000 claims 1
- 230000036039 immunity Effects 0.000 claims 1
- 210000004698 lymphocyte Anatomy 0.000 claims 1
- 238000012216 screening Methods 0.000 claims 1
- 230000028327 secretion Effects 0.000 claims 1
- 230000002381 testicular Effects 0.000 claims 1
- 102100034671 L-lactate dehydrogenase A chain Human genes 0.000 abstract description 8
- 108020001507 fusion proteins Proteins 0.000 abstract description 7
- 102000037865 fusion proteins Human genes 0.000 abstract description 6
- 241001465754 Metazoa Species 0.000 abstract description 2
- 238000012215 gene cloning Methods 0.000 abstract 1
- 238000011160 research Methods 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 230000006870 function Effects 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 230000021595 spermatogenesis Effects 0.000 description 3
- 102000014914 Carrier Proteins Human genes 0.000 description 2
- 108010078791 Carrier Proteins Proteins 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241000237988 Patellidae Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- 238000007877 drug screening Methods 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 230000001850 reproductive effect Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 238000009007 Diagnostic Kit Methods 0.000 description 1
- 108700039887 Essential Genes Proteins 0.000 description 1
- 101000988834 Homo sapiens Hypoxanthine-guanine phosphoribosyltransferase Proteins 0.000 description 1
- 102100029098 Hypoxanthine-guanine phosphoribosyltransferase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- 108700036935 Lactate dehydrogenase deficiency type A Proteins 0.000 description 1
- 208000007466 Male Infertility Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 102100026918 Phospholipase A2 Human genes 0.000 description 1
- 108010058864 Phospholipases A2 Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 description 1
- 102000004282 Ribosomal protein S9 Human genes 0.000 description 1
- 108090000878 Ribosomal protein S9 Proteins 0.000 description 1
- 108090000848 Ubiquitin Proteins 0.000 description 1
- 102000044159 Ubiquitin Human genes 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 230000003509 anti-fertility effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000006957 competitive inhibition Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 208000023875 glycogen storage disease due to lactate dehydrogenase M-subunit deficiency Diseases 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000011532 immunohistochemical staining Methods 0.000 description 1
- 238000001114 immunoprecipitation Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000004850 protein–protein interaction Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 210000004989 spleen cell Anatomy 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
本发明属于人类基因组技术领域,所述人睾丸新型乳酸脱氢酶A基因(Novel lactate dehydrogenase A)基因全长cDNA序列为1680bp,其开放阅读框为1146bp,编码382个氨基酸,该基因在基因库(Genbank)中的编号为AY009108。利用本发明的人睾丸新型乳酸脱氢酶A基因表达克隆,可制备融合蛋白,用该蛋白免疫动物可制备单克隆和多克隆抗体,并可将基因克隆用于睾丸特异功能基因表达芯片的制备。The invention belongs to the field of human genome technology. The full-length cDNA sequence of the human testis novel lactate dehydrogenase A gene (Novel lactate dehydrogenase A) gene is 1680bp, its open reading frame is 1146bp, and encodes 382 amino acids. (Genbank) number AY009108. Using the novel human testis lactate dehydrogenase A gene expression clone of the present invention, a fusion protein can be prepared, the protein can be used to immunize animals to prepare monoclonal and polyclonal antibodies, and the gene cloning can be used for the preparation of testis-specific functional gene expression chips .
Description
本发明属于人类基因组技术领域。The invention belongs to the technical field of human genome.
本发明所述人睾丸新型乳酸脱氢酶A基因是发明人在南京医科大学生殖医学江苏省重点实验室用基因芯片方法筛选获得,首先制备人睾丸功能基因表达芯片,通过比较胚胎和成年人睾丸功能基因的表达,获得差异表达克隆,经序列测定证明为全长cDNA,为1680bp:其开放阅读框架为1146bp,其编码382个氨基酸。查阅基因库,可见小鼠体内有一同源基因,为乳酸脱氢酶A基因,但与人类乳酸脱氢酶基因无同源性。由于该基因是成人睾丸高表达,而胚胎与成人睾丸的主要差别是后者有精子发生,因此发现的人睾丸新型乳酸脱氢酶A很可能与精子发生相关,用该基因克隆,可制备成融合蛋白,用该蛋白免疫家兔,可获得单克隆和多克隆抗体,该基因也可用于制备睾丸功能基因表达芯片。The novel human testis lactate dehydrogenase A gene described in the present invention was obtained by the inventors in Jiangsu Key Laboratory of Reproductive Medicine of Nanjing Medical University by gene chip method. For the expression of functional genes, differentially expressed clones were obtained, which were proved to be full-length cDNAs of 1680 bp by sequence determination: its open reading frame was 1146 bp, and it encoded 382 amino acids. Checking the gene bank, it can be seen that there is a homologous gene in the mouse body, which is the lactate dehydrogenase A gene, but it has no homology with the human lactate dehydrogenase gene. Since this gene is highly expressed in adult testes, and the main difference between embryos and adult testes is that the latter has spermatogenesis, the new lactate dehydrogenase A discovered in human testis is likely to be related to spermatogenesis. Cloning with this gene can be prepared into The fusion protein can be used to immunize rabbits to obtain monoclonal and polyclonal antibodies, and the gene can also be used to prepare a testis functional gene expression chip.
由于人睾丸新型乳酸脱氢酶A基因在Genbank数据库中尚无人的同源基因,本发明人对于该基因的结构和功能研究成果全都是开创性的。美国国家生物技术情报中心(National Center for BiotechnologyInformation,NCBI)已正式接受该基因为Genbank的新成员,接受号为AY009108。1 agagtgctga aggtcctgcc aacggctctc ttggcgtctc aacgttcgga tcagcagctt61 ttttccattc tctctctcca cttcttcagt gagcagccat gagttggact gtgcctgttg121 tgcgggccag ccagagagtg agctcggtgg gagcgaattt cctatgcctg gggatggccc181 tgtgtccgcg tcaagcaacg cgcatcccgc tcaacggcac ctggctcttc acccccgtga241 gcaagatggc gactgtgaag agtgagctta ttgagcgttt cacttccgag aagcccgttc301 atcacagtaa ggtctccatc ataggaactg gatcggtggg catggcctgc gctatcagca361 tcttattaaa aggcttgagt gatgaacttg cccttgtgga tcttgatgaa gacaaactga421 agggtgagac gatggatctt caacatggca gccctttcac gaaaatgcca aatattgttt481 gtagcaaaga ttactttgtc acagcaaact ccaacctagt gattatcaca gcaggtgcac541 gccaagaaaa gggagaaacg cgccttaatt tagtccagcg aaatgtggcc atcttcaagt601 taatgatttc cagtattgtc cagtacagcc cccactgcaa actgattatt gtttccaatc661 cagtggatat cttaacttat gtagcttgga agttgagtgc atttcccaaa aaccgtatta721 ttggaagcgg ctgtaatctg gatactgctc gttttcgttt cttgattgga caaaagcttg781 gtatccattc tgaaagctgc catggatgga tcctcggaga gcatggagac tcaagtgttc841 ctgtgtggag tggagtgaac atagctggtg tccctttgaa ggatctgaac tctgatatag901 gaactgataa agatcctgag caatggaaaa atgtccacaa agaagtgact gcaactgcct961 atgagattat taaaatgaaa ggttatactt cttgggccat tggcctatct gtggccgatt1021 taacagaaag tattttgaag aatcttagga gaatacatcc agtttccacc ataattaagg1081 gcctctatgg aatagatgaa gaagtattcc tcagtattcc ttgtatcctg ggagagaacg1141 gtattaccaa ccttataaag ataaagctga cccctgaaga agaggcccat ctgaaaaaaa1201 gtgcaaaaac actctgggaa attcagaata agcttaagct ttaaagttgc ctaaaactac1261 cattccgaaa ttattgaaga gatcatagat acaggattat ataacgaaat tttgaataaa1321 cttgaattcc taaaagatgg aaacaggaaa gtaggtagag tgattttcct atttatttag1381 tcctccagct cttttattga gcatccacgt gctggacgat acttatttac aattcctaag1441 tatttttggt acctctgatg tagcagcact tgccatgtta tatatatgta gttggcattt1501 ggttcccaaa aagtaggatg taggtattta ttgtgttcta gaaattccga ctcttttcat1561 tagatatatg ctatttcttt cattcttgct ggtttatacc tatgttcatt tatatgctgt1621 aaaaaagtag tagcttcttc tacaatgtaa aaataaatgt acatacaaaa aaaaaaaaaa人睾丸新型乳酸脱氢酶A基因cDNA序列MSWTVPVVRASQRVSSVGANFLCLGMALCPRQATRIPLNGTWLFTPVSKMATVKSELIERFTSEKPVHHSKVSIIGTGSVGMACAISILLKGLSDELALVDLDEDKLKGETMDLQHGSPFTKMPNIVCSKDYFVTANSNLVIITAGARQEKGETRLNLVQRNVAIFKLMISSIVQYSPHCKLIIVSNPVDILTYVAWKLSAFPKNRIIGSGCNLDTARFRFLIGQKLGIHSESCHGWILGEHGDSSVPVWSGVNIAGVPLKDLNSDIGTDKDPEQWKNVHKEVTATAYEIIKMKGYTSWAIGLSVADLTESILKNLRRIHPVSTIIKGLYGIDEEVFLSIPCILGENGITNLIKIKLTPEEEAHLKKSAKTLWEIQNKLKL人睾丸新型乳酸脱氢酶A基因开放阅读框架氨基酸序列Since the novel lactate dehydrogenase A gene of human testis has no homologous gene in the Genbank database, the inventors' research results on the structure and function of this gene are all groundbreaking.美国国家生物技术情报中心(National Center for BiotechnologyInformation,NCBI)已正式接受该基因为Genbank的新成员,接受号为AY009108。1 agagtgctga aggtcctgcc aacggctctc ttggcgtctc aacgttcgga tcagcagctt61 ttttccattc tctctctcca cttcttcagt gagcagccat gagttggact gtgcctgttg121 tgcgggccag ccagagagtg agctcggtgg gagcgaattt cctatgcctg gggatggccc181 tgtgtccgcg tcaagcaacg cgcatcccgc tcaacggcac ctggctcttc acccccgtga241 gcaagatggc gactgtgaag agtgagctta ttgagcgttt cacttccgag aagcccgttc301 atcacagtaa ggtctccatc ataggaactg gatcggtggg catggcctgc gctatcagca361 tcttattaaa aggcttgagt gatgaacttg cccttgtgga tcttgatgaa gacaaactga421 agggtgagac gatggatctt caacatggca gccctttcac gaaaatgcca aatattgttt481 gtagcaaaga ttactttgtc acagcaaact ccaacctagt gattatcaca gcaggtgcac541 gccaagaaaa gggagaaacg cgccttaatt tagtccagcg aaatgtggcc atcttcaagt601 taatgatttc cagtattgtc cagtacagcc cccactgcaa actgattatt gtttccaatc661 cagtggatat cttaacttat gtagcttgga agttgagtgc atttcccaaa aaccgtatta721 ttggaagcgg ctgtaatctg gatactgctc gttttcgttt cttgattgga caaaagcttg781 gtatccattc tgaaagctgc catggatgga tcctcggaga gcatggagac tcaagtgttc841 ctgtgtggag tggagtgaac atagctggtg tccctttgaa ggatctgaac tctgatatag901 gaactgataa agatcctgag caatggaaaa atgtccacaa agaagtgact gcaactgcct961 atgagattat taaaatgaaa ggttatactt cttgggccat tggcctatct gtggccgatt1021 taacagaaag tattttgaag aatcttagga gaatacatcc agtttccacc ataattaagg1081 gcctctatgg aatagatgaa gaagtattcc tcagtattcc ttgtatcctg ggagagaacg1141 gtattaccaa ccttataaag ataaagctga cccctgaaga agaggcccat ctgaaaaaaa1201 gtgcaaaaac actctgggaa attcagaata agcttaagct ttaaagttgc ctaaaactac1261 cattccgaaa ttattgaaga gatcatagat acaggattat ataacgaaat tttgaataaa1321 cttgaattcc taaaagatgg aaacaggaaa gtaggtagag tgattttcct atttatttag1381 tcctccagct cttttattga gcatccacgt gctggacgat acttatttac aattcctaag1441 tatttttggt acctctgatg tagcagcact tgccatgtta tatatatgta gttggcattt1501 ggttcccaaa aagtaggatg taggtattta ttgtgttcta gaaattccga ctcttttcat1561 tagatatatg ctatttcttt cattcttgct ggtttatacc tatgttcatt tatatgctgt1621 aaaaaagtag tagcttcttc tacaatgtaa aaataaatgt acatacaaaa aaaaaaaaaa人睾丸新型乳酸脱氢酶A基因cDNA序列MSWTVPVVRASQRVSSVGANFLCLGMALCPRQATRIPLNGTWLFTPVSKMATVKSELIERFTSEKPVHHSKVSIIGTGSVGMACAISILLKGLSDELALVDLDEDKLKGETMDLQHGSPFTKMPNIVCSKDYFVTANSNLVIITAGARQEKGETRLNLVQRNVAIFKLMISSIVQYSPHCKLIIVSNPVDILTYVAWKLSAFPKNRIIGSGCNLDTARFRFLIGQKLGIHSESCHGWILGEHGDSSVPVWSGVNIAGVPLKDLNSDIGTDKDPEQWKNVHKEVTATAYEIIKMKGYTSWAIGLSVADLTESILKNLRRIHPVSTIIKGLYGIDEEVFLSIPCILGENGITNLIKIKLTPEEEAHLKKSAKTLWEIQNKLKL人睾丸新型乳酸脱氢酶A基因开放阅读框架氨基酸序列
本发明的目的是:鉴于人睾丸新型乳酸脱氢酶A基因是本发明人发现的全新基因,目前人类对此基因的认识和了解仅限于本发明人所做的科学研究工作。由于该基因是与睾丸特异功能相关的基因,而且是胚胎低表达,成人高表达,因此该基因很可能与睾丸内的精子发生有关,其异常表达可能影响男性的生殖功能,因此该基因的研究可用于:①通过制备该基因的融合蛋白,用于研究该基因与睾丸功能的关系,还可能成为一种治疗男性睾丸相关疾病的生物药品。The purpose of the present invention is: in view of the fact that the novel lactate dehydrogenase A gene of human testis is a brand-new gene discovered by the inventor, the current human knowledge and understanding of this gene is limited to the scientific research work done by the inventor. Since this gene is a gene related to the specific function of the testis, and its expression is low in embryos and high in adults, it is likely to be related to spermatogenesis in the testis, and its abnormal expression may affect male reproductive function. Therefore, the study of this gene It can be used for: ①Preparing the fusion protein of the gene to study the relationship between the gene and the function of the testis, and may also become a biological drug for treating diseases related to the testis of men.
②制备特异性抗体:基因编码蛋白的特异性抗体是研究基因结构和功能的不可缺少的重要工具,人睾丸新型乳酸脱氢酶A基因编码蛋白的多克隆和单克隆抗体,可用作免疫组织化学染色、ELlSA、免疫电镜、免疫共沉淀等多种根据免疫学原理设计的检测方法,可用于该基因编码蛋白在组织细胞中的定位和定量研究,也可用于各种生物样本(如血液、精液、尿液等)中的含量变化研究以及蛋白质-蛋白质相互作用研究等。因此,该抗体有可能用于制备与人睾丸新型乳酸脱氢酶A基因表达异常相关疾病诊断试剂盒,并有可能用于制备抗生育药物。②Preparation of specific antibodies: Specific antibodies to gene-encoded proteins are an indispensable and important tool for studying gene structure and function. Polyclonal and monoclonal antibodies to proteins encoded by the new lactate dehydrogenase A gene of human testis can be used as immune tissue Chemical staining, ELlSA, immunoelectron microscopy, immunoprecipitation and other detection methods designed according to immunological principles can be used for the localization and quantitative research of the protein encoded by the gene in tissue cells, and can also be used for various biological samples (such as blood, Semen, urine, etc.) content change research and protein-protein interaction research, etc. Therefore, the antibody may be used to prepare a diagnostic kit for diseases related to the abnormal expression of the new lactate dehydrogenase A gene in human testis, and may be used to prepare antifertility drugs.
③制备基因诊断芯片:将功能基因用于制备基因诊断芯片是基因开发研究的一个重要方面,在疾病诊断(如男性不育、性功能低下)和药物筛选等方面均具有重要意义。本发明技术方案1.人睾丸新型乳酸脱氢酶A基因融合蛋白的制备③Preparation of genetic diagnostic chips: The use of functional genes in the preparation of genetic diagnostic chips is an important aspect of gene development research, and is of great significance in disease diagnosis (such as male infertility, low sexual function) and drug screening. Technical solution of the present invention 1. Preparation of Novel Lactate Dehydrogenase A Gene Fusion Protein from Human Testis
以人睾丸新型乳酸脱氢酶A基因开放阅读框的核苷酸序列与质粒pDESTTM15制备成GST-SP2-pDEST15表达质粒,在无NaCl的LB中30C培养到0.5 OD600,经0.3MNaCl诱导后,超声粉碎后经GST亲和层析柱纯化,得到纯化的融合蛋白。2.人睾丸新型乳酸脱氢酶A基因编码蛋白特异性多克隆抗体The GST-SP2-pDEST15 expression plasmid was prepared with the nucleotide sequence of the open reading frame of the new human testis lactate dehydrogenase A gene and the plasmid pDEST TM 15, cultured in LB without NaCl at 30C to 0.5 OD600, and induced by 0.3M NaCl , purified by GST affinity chromatography column after ultrasonic pulverization to obtain purified fusion protein. 2. Human testis novel lactate dehydrogenase A gene-encoded protein-specific polyclonal antibody
取融合蛋白与载体蛋白KLH(Keyhole Limpet Hymocyanin)结合,经透析后再与完全/不完全佐剂(Complete/Incomplete Freund’sAdjuvant)等量混合,免疫新西兰兔(背部皮下注射),每隔3~4周激发注射一次,共三次,于三个月后取血分离血清。以免疫前动物血清作为对照做ELISA,测定各免疫兔血清中抗体滴度。筛选高滴度血清,进一步用抗原作竞争抑制免疫试验确定抗体的特异性。根据ELISA结果确定其用于免疫组织化学染色的稀释倍增数为1∶200~500。3.人睾丸新型乳酸脱氢酶A基因编码蛋白特异性单克隆抗体Combine the fusion protein with the carrier protein KLH (Keyhole Limpet Hymocyanin), and then mix it with an equal amount of complete/incomplete adjuvant (Complete/Incomplete Freund's Adjuvant) after dialysis, and immunize New Zealand rabbits (subcutaneous injection in the back), every 3~ Inject once every 4 weeks for a total of three times, and blood was collected three months later to separate serum. ELISA was performed with the animal serum before immunization as a control, and the antibody titer in each immunized rabbit serum was determined. Screen high-titer sera, and further use the antigen as a competitive inhibition immunoassay to determine the specificity of the antibody. According to the results of ELISA, the dilution doublings for immunohistochemical staining were determined to be 1:200-500.3. Human testis novel lactate dehydrogenase A gene-encoded protein-specific monoclonal antibody
取融合蛋白与载体蛋白KLH(Keyhole Limpet Hymocyanin)结合,经透析后再与完全/不完全佐剂(Complete/Incomplete Freund’sAdjuvant)混合,免疫Balb/C小鼠(腹腔内注射),隔周一次,连续2-3次,融合前静脉加强一次,用ELISA方法证实抗体的产生后,取脾脏分离脾细胞,然后与骨髓瘤细胞融合产生杂交瘤细胞。阳性克隆经多次亚克隆,直至获得分泌抗人睾丸新型乳酸脱氢酶A的单克隆杂交瘤细胞株。4.人睾丸新型乳酸脱氢酶A基因用于制备睾丸功能基因表达芯片Combine the fusion protein with the carrier protein KLH (Keyhole Limpet Hymocyanin), and then mix it with complete/incomplete adjuvant (Complete/Incomplete Freund's Adjuvant) after dialysis, and immunize Balb/C mice (intraperitoneal injection), once every other week , 2-3 times in a row, and the vein was strengthened once before fusion. After confirming the production of antibodies by ELISA method, the spleen was taken to separate spleen cells, and then fused with myeloma cells to produce hybridoma cells. Positive clones were subcloned multiple times until a monoclonal hybridoma cell line secreting a new type of lactate dehydrogenase A resistant to human testis was obtained. 4. A novel human testis lactate dehydrogenase A gene was used to prepare a testis functional gene expression chip
(1)以获取的人睾丸新型乳酸脱氢酶A基因的核苷酸序列设计引物,扩增全长的人睾丸新型乳酸脱氢酶A序列,用作点膜的样品。(2)用英国BioRobotics自动点膜仪将标本点在8×12cm尼龙膜上,每一标本点2个点,每点的DNA量约几ng。;阳性对照8个housekeeping genes (a.ribosomal protein S9;b.Actin gamma;c.glyceraldehyde-3-phosphate dehydrogenase;d.hypoxanthinephosphoribosyltransferase 1;e.H.sapiens mRNA for 23KD highly basicprotein;f.ubiqnitin C;g.Phospholipase A2;h.ubiquitin carboxy Ⅰ-ferminalesterase L Ⅰ)。阴性对照加入噬菌体DNA和P-blue质粒。(3)将含有该基因的芯片用于人睾丸新型乳酸脱氢酶A缺失的诊断和药物筛选33P标记:(1) Design primers with the obtained nucleotide sequence of human testis novel lactate dehydrogenase A gene, amplify the full-length human testis novel lactate dehydrogenase A sequence, and use it as a sample for spotting membrane. (2) Use the British BioRobotics automatic film spotting instrument to spot the specimens on an 8×12 cm nylon membrane, 2 spots for each sample, and the amount of DNA in each spot is about a few ng. ; positive control 8 housekeeping genes (a.ribosomal protein S9; b.Actin gamma; c.glyceraldehyde-3-phosphate dehydrogenase; d.hypoxanthinephosphoribosyltransferase 1; eHsapiens mRNA for 23KD highly basicprotein; f.ubiqnitin C; g.Phospholipase A2; h.ubiquitin carboxy Ⅰ-ferminalesterase L Ⅰ). Phage DNA and P-blue plasmid were added as negative controls. (3) The chip containing the gene is used for the diagnosis and drug screening of human testis novel lactate dehydrogenase A deficiency 33 P marker:
抽提待检标本mRNA或DNA,用Random Primer标记法标记待检标本mRNA或DNA,作为杂交的探针。杂交:Extract the mRNA or DNA of the sample to be tested, and use the Random Primer labeling method to label the mRNA or DNA of the sample to be tested as a probe for hybridization. hybridization:
将点制好的尼龙膜标记探针杂交后,杂交炉(68℃)内烘干,用磷屏压片。信号扫描和分析:After hybridizing the prepared nylon membrane-labeled probes, dry them in a hybridization oven (68° C.), and press them with a phosphor screen. Signal Scanning and Analysis:
用记录仪分析杂交信号。根据杂交信号的强弱分析影响人睾丸新型乳酸脱氢酶A蛋白表达水平或人睾丸新型乳酸脱氢酶A基因的缺失。Hybridization signals were analyzed with a recorder. According to the analysis of the strength of the hybridization signal, it affects the expression level of human testis novel lactate dehydrogenase A protein or the deletion of human testis novel lactate dehydrogenase A gene.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 01108262 CN1313342A (en) | 2001-02-28 | 2001-02-28 | Human testis lactate dehydrogenase A gene coded protein |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 01108262 CN1313342A (en) | 2001-02-28 | 2001-02-28 | Human testis lactate dehydrogenase A gene coded protein |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1313342A true CN1313342A (en) | 2001-09-19 |
Family
ID=4657143
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 01108262 Pending CN1313342A (en) | 2001-02-28 | 2001-02-28 | Human testis lactate dehydrogenase A gene coded protein |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1313342A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102576022A (en) * | 2009-08-14 | 2012-07-11 | 加利福尼亚大学董事会 | Methods of diagnosing and treating autism |
-
2001
- 2001-02-28 CN CN 01108262 patent/CN1313342A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102576022A (en) * | 2009-08-14 | 2012-07-11 | 加利福尼亚大学董事会 | Methods of diagnosing and treating autism |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107108733B (en) | Anti-active GIP antibody | |
JP2003510053A (en) | Heparanase-2, a member of the heparanase protein family | |
CN1313342A (en) | Human testis lactate dehydrogenase A gene coded protein | |
CN112540176B (en) | Kit, method and computer-readable storage medium for diagnosing diseases associated with FAP expression abnormality | |
CN1316434A (en) | Human specific protein kinase-15 gene coding protein | |
CN1319665A (en) | Human testics kinesin 9 gene coding protein | |
CN1309138A (en) | Human testicular cytodifferentiation related protein gene coded protein | |
CN1319662A (en) | Human testicular ubiquitin specific proteinase-10 gene coding protein | |
CN1309137A (en) | Human testicular gastrulation protein gene coded protein | |
CN1318554A (en) | Human testicular development specific protein-11 gene encoded protein | |
CN114316041B (en) | Preparation method of NLS-RAR alpha monoclonal antibody, rapid detection card based on antibody and preparation method of rapid detection card | |
CN1318559A (en) | Human sperm skelemin gene encoded protein | |
CN1319660A (en) | Human testis specific protein kinase gene coding protein | |
CN1313340A (en) | Human sperm-specific protein 2 gene coded protein | |
CN1318560A (en) | Human testicular specific protein-1 gene encoded protein | |
CN1318557A (en) | Human testicular specific protein-10 gene encoded protein | |
CN1318558A (en) | Human testicular development specific protein-12 gene encoded protein | |
CN1316435A (en) | Human testicular development specificity protein-8 gene coding protein | |
CN1382694A (en) | Human testis development specific protein-17 gene coding protein | |
CN1318562A (en) | Human testicular development specific protein-14 gene encoded protein | |
CN1344740A (en) | Human testicular development specific protein-20 gene encoding protein | |
CN1318563A (en) | Human testicular development specific protein-6 gene encoded protein | |
CN1344735A (en) | Human testicular development specific protein-19 gene encoding protein | |
CN1308087A (en) | Human testis specific protein gene coding protein | |
CN1344744A (en) | Human testicular development specific protein-27 gene encoding protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |